bioRxiv · 10.1101/363572
Molecular Complexes for Effective Inhibition of Tau Aggregation
Abstract
Tau is an axonal protein known to form abnormal aggregates and is the biomarker of Alzheimers disease. Metal-based therapeutics for inhibition of Tau aggregation is limited and rarely reported in the contemporary science. Here, the first example is reported of a rationally designed molecular cobalt(II)-complexes for effective inhibition of Tau and disaggregation of preformed Tau fibrils. The mechanistic studies revealed that the prevention of Tau aggregation by CBMCs is concentration-dependent and Tau seldom exhibits conformational changes. Interestingly, CBMCs play a dual role by causing disassembly of preformed aggregates as well as complete Tau inhibition. We believe that this unprecedented finding by the newly developed molecular complexes has a potential to lead to developing innovative metal-based therapeutics for Alzheimers disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Gorantla, N. V., Landge, V. G., Nagaraju, P. G., Sunny, L. P., Nair, A., Midya, S. P., Priyadarshini, P., Ekambaram, B., Chinnathambi, S.. 2018-07-06. Molecular Complexes for Effective Inhibition of Tau Aggregation. https://doi.org/10.1101/363572
Cite the original work for its findings. Save a collection to share your selection of sources.